FMC falls after Barclays cuts to 'underweight' on earnings concerns
BUZZ-FMC falls after Barclays cuts to 'underweight' on earnings concerns ** Shares in Fresenius Medical Care AG FMEG.DE fall around 3% in early Frankfurt trade after Barclays cut its rating on the dialysis group to "underweight" from "equal weight"
** It cites concerns over earnings outlook due to reimbursement pressure, treatment growth and inflation
** The broker sees "meaningful downside risk" to FMC's medium-term targets, forecasting a 3% EBIT decline over 2025-2028 versus management's 3%-7% growth target
** The downgrade follows FMC's third-quarter results on Tuesday, when the company trimmed the upper end of its 2026 operating income outlook as US treatment volumes continued to fall
** Barclays also flags a potential selldown by Fresenius FREn.DE, which still owns a 25% stake in FMC, as a risk
** It cuts its PT on the stock to €35 from €44.50; shares were up 3.6% year-to-date at Friday's close
($1 = 0.8961 euros)
(Reporting by Kira Britten)
Recent news on Fresenius Medical Care AG
See all newsFMC seen down as Fresenius cuts stake to 20%
Germany's Fresenius cuts FMC stake to 20%
Brief: Fresenius Investment In Fresenius Medical Care Reduced From Approximately 25% To Approximately 20% Of Issued Share Capital
Brief: Fresenius Medical Care AG ABB Orders Below Eur 39.00 Per Share, Says Book Runner
Brief: Bookrunner Says Fresenius Medical ABB C. 13.4 Mln Shares, Books Are Closed